| 000 | 01832 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250515190501.0 | ||
| 264 | 0 | _c20100813 | |
| 008 | 201008s 0 0 eng d | ||
| 022 | _a1468-3083 | ||
| 024 | 7 |
_a10.1111/j.1468-3083.2009.03446.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aOcvirk, J | |
| 245 | 0 | 0 |
_aManagement of cutaneous side-effects of cetuximab therapy in patients with metastatic colorectal cancer. _h[electronic resource] |
| 260 |
_bJournal of the European Academy of Dermatology and Venereology : JEADV _cApr 2010 |
||
| 300 |
_a453-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAcneiform Eruptions _xchemically induced |
| 650 | 0 | 4 | _aAdministration, Topical |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadministration & dosage |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 | _aCetuximab |
| 650 | 0 | 4 |
_aColorectal Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aConjunctivitis _xchemically induced |
| 650 | 0 | 4 |
_aDrug Eruptions _xdrug therapy |
| 650 | 0 | 4 |
_aEmollients _xadministration & dosage |
| 650 | 0 | 4 |
_aErbB Receptors _ximmunology |
| 650 | 0 | 4 |
_aEyelashes _xdrug effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHair Diseases _xchemically induced |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aParonychia _xchemically induced |
| 650 | 0 | 4 | _aQuality of Life |
| 650 | 0 | 4 |
_aTelangiectasis _xchemically induced |
| 700 | 1 | _aCencelj, S | |
| 773 | 0 |
_tJournal of the European Academy of Dermatology and Venereology : JEADV _gvol. 24 _gno. 4 _gp. 453-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1468-3083.2009.03446.x _zAvailable from publisher's website |
| 999 |
_c19188871 _d19188871 |
||